OTC Drug Bitter Taste-Blocking Compound Receives $746,000 NIH Grant
This article was originally published in The Tan Sheet
Executive Summary
NIH-funded research evaluating the efficacy of a bitter taste-inhibiting compound could result in the development of "more palatable" oral OTC drugs and subsequent improvements in patient compliance, according to grantee Linguagen Corp